Navigation Links
Global Webinar Focuses on Considerations for Extractables and Leachables
Date:5/16/2012

AMSTERDAM, May 16, 2012 /PRNewswire/ -- Leading events organiser UBM Conferences, a division of UBM Plc (LSE: UBM),  today announced details of the forthcoming CPhI Extractables and Leachables Webinar to be hosted on May 17th, 2012 at 2pm IST/9:30am GMT/4:30pm CST. The free to attend webinar will evaluate the considerations to be made when using extractables and leachables and during drug development, in addition to highlighting how monomers and additives, such as antioxidants, plasticisers, and stabilisers, should be evaluated for potential migration into final medicinal products. Featured topics will include current regulatory guidelines, approaches to designing extractable and leachable studies, evaluation and qualification of finished containers, what process materials to use in pharmaceutical production, as well as ICH and global pharmacopeial guidelines and regulations.

"The goal of this webinar is to provide attendees with an understanding of current regulatory requirements and expectations and how to apply them to the design of extractable and leachable studies," noted Ferdinand Dabu, UBM Conferences. He added, "This event takes advantage of an offsite format that is easy to attend and justify financially. Through the use of the webinar format, our attendees can tune in and listen to key industry players talking about real issues that will be directly applicable to their own laboratory testing practices and help them to find new ways to guarantee supply chain security."

The Extractables and Leachables Webinar will be presented by top industry experts from Boehringer Ingelheim and SGS Life Science Services. Because of the format, it will provide a unique platform for pharmaceutical manufacturing professionals to learn and network with other industry players on ways to improve their individual pharmaceutical manufacturing supply chains.

To learn more about the event, or to register, please visit: http://www.cphi.com/sgs

 

 


'/>"/>
SOURCE UBM Conferences
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. MacroGenics Begins Global Phase 2/3 Protege Study in Recent-onset Type 1 Diabetes Mellitus
2. Dr. Roger Kenneth Hershline PhD MD, CEO of Global Humanceuticals, Inc. Donates New HIV Drug
3. Directors Forum: PEPFAR and the Global AIDS Response
4. Alfacell Corporation to Present at UBS Global Life Sciences Conference
5. Baxa Corporation Extends Global Reach With New Distribution Agreements in Colombia and the Dominican Republic
6. Global HIV Vaccine Enterprise Names Alan Bernstein as Inaugural Executive Director, Opens New Secretariat
7. President Clinton Highlights MWW Group at the 2007 Clinton Global Initiative for its Stop Neglected Tropical Disease Campaign
8. Hillary Clinton Pledges Bold Approach to Stopping HIV/AIDS & Global Poverty
9. IBA and Elekta Initiate Global Particle Therapy Program at ASTRO
10. Dr. Rajeev Venkayya Joins Gates Foundation as Director of Global Health Delivery
11. BioNumerik Commences Global Phase III Ovarian Cancer Trial on Novel Anticancer Drug Candidate Known as Karenitecin(R)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/25/2017)... 25, 2017   Montrium , an industry ... today—from the IQPC Trial Master Files & Inspection ... that EastHORN Clinical Services has selected eTMF ... TMF management. EastHORN, a leading European contract research ... increase transparency to enable greater collaboration with sponsors, ...
(Date:9/19/2017)... Mich. , Sept. 19, 2017 HistoSonics, Inc., a venture-backed medical device company ... destruction of targeted tissues, announced three leadership team developments today:   ... PhD ... ... Veteran medical device executive Josh ...
(Date:9/12/2017)... NEW YORK , Sept. 12, 2017   EcoVadis ... global supply chains, has published the first annual edition of its Global ... more than 20,400 companies evaluated by EcoVadis, based on Scorecard Ratings that ... ... Risk & Performance Index ...
Breaking Medicine Technology:
(Date:10/12/2017)... ... October 12, 2017 , ... Information about the technology: ... develop to enable prevention of a major side effect of chemotherapy in children. ... pediatric patients. For cisplatin, hearing loss is FDA listed on-label as a dose ...
(Date:10/12/2017)... , ... October 12, 2017 , ... HMP , ... recipient of a 2017 Folio Magazine Eddie Digital Award for ‘Best B-to-B Healthcare Website.’ ... on October 11, 2017. , The annual award competition recognizes editorial and design excellence ...
(Date:10/12/2017)... FL (PRWEB) , ... October 12, 2017 , ... On ... holding a treadmill relay – Miles by Moonlight to raise money for the American ... $300 or more. , Teams will work together to keep their treadmills moving ...
(Date:10/12/2017)... , ... October 12, 2017 , ... ... the nation's first interactive health literacy software tool, and the Cancer Patient Education ... of cancer patient education, today announce a new strategic alliance. , As ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... wound care advancements to physician colleagues, skilled nursing facility medical directors and other ... Treacherous Waters of Wound Care." , "At many of these conferences we get ...
Breaking Medicine News(10 mins):